Indaptus Therapeutics is trading 7.02% up now at $1.22, supported by the Nasdaq rising 1.34% and S&P 500 gaining 0.59%.
- No new company-specific announcement dated August 27, 2026, was identified.
- An August 17 prospectus covers the resale of up to 58,895,000 shares by selling stockholders.
- Second-quarter results were released August 13.